{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:19:57Z","timestamp":1793834397968,"version":"4.6.1"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16GRNT26430041"],"award-info":[{"award-number":["16GRNT26430041"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elizabeth Daniell Research Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.atherosclerosis.2018.08.046","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T14:35:00Z","timestamp":1535639700000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"special_numbering":"C","title":["CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies"],"prefix":"10.1016","volume":"278","author":[{"given":"Allison B.","family":"Reiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora J.","family":"Kasselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Voloshyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert","family":"D'Avino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.2016121374","article-title":"Update on the burden of CKD","volume":"28","author":"Coresh","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9963","key":"10.1016\/j.atherosclerosis.2018.08.046_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Collaborators GMaCoD","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MNH.0000000000000315","article-title":"Recent trends in the prevalence of chronic kidney disease: not the same old song","volume":"26","author":"Hsu","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.amepre.2017.02.015","article-title":"State-level awareness of chronic kidney disease in the U.S","volume":"53","author":"Dharmarajan","year":"2017","journal-title":"Am. J. Prev. Med."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.08.046_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in prevalence of chronic kidney disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2018.08.046_bib6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.08.046_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib8","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.08.046_bib9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib10","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1 alpha-hydroxylase expression in vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib11","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.mnh.0000232885.81142.83","article-title":"Klotho as a regulator of fibroblast growth factor signaling and phosphate\/calcium metabolism","volume":"15","author":"Kuro-o","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3122\/jabfm.2009.05.090026","article-title":"Secondary hyperparathyroidism: pathophysiology and treatment","volume":"22","author":"Saliba","year":"2009","journal-title":"J. Am. Board Fam. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.18553\/jmcp.2007.13.5.397","article-title":"Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment","volume":"13","author":"Joy","year":"2007","journal-title":"J. Manag. Care Pharm."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0272-6386(97)90086-X","article-title":"Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure","volume":"30","author":"Kates","year":"1997","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.08.046_bib17","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro","volume":"11","author":"Almaden","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.08.046_bib18","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.08.046_bib20","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1359\/jbmr.2002.17.12.2094","article-title":"Pathophysiology and recent advances in the management of renal osteodystrophy","volume":"17","author":"Elder","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib21","first-page":"135","article-title":"Adynamic bone disease-bone and beyond","volume":"1","author":"Brandenburg","year":"2008","journal-title":"NDT Plus"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.08.046_bib22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.08.046_bib25","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2862","article-title":"Hip fracture in patients with non-dialysis-requiring chronic kidney disease","volume":"31","author":"Kim","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ki.2013.302","article-title":"Fractures in chronic kidney disease: neglected, common, and associated with sickness and death","volume":"85","author":"Fusaro","year":"2014","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib29","doi-asserted-by":"crossref","unstructured":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int. Suppl.7(1):1-59.","DOI":"10.1016\/j.kisu.2017.04.001"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/iub.437","article-title":"Osteo-renal regulation of systemic phosphate metabolism","volume":"63","author":"Razzaque","year":"2011","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.08.046_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","article-title":"Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?","volume":"34","author":"Evenepoel","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.kint.2015.10.001","article-title":"Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high?","volume":"89","author":"O'Neill","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/j.ajkd.2013.04.012","article-title":"Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population","volume":"62","author":"Taliercio","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"98","key":"10.1016\/j.atherosclerosis.2018.08.046_bib36","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1523-1755.2005.09805.x","article-title":"The kidney, a cardiovascular risk marker, and a new target for therapy","author":"de Zeeuw","year":"2005","journal-title":"Kidney Int. Suppl."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2018.08.046_bib37","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","article-title":"Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors","volume":"293","author":"Shlipak","year":"2005","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.08.046_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archinternmed.2011.230","article-title":"Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease","volume":"171","author":"Minutolo","year":"2011","journal-title":"Arch. Intern. Med."},{"issue":"9889","key":"10.1016\/j.atherosclerosis.2018.08.046_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.08.046_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2215\/CJN.01240215","article-title":"Predictors of subclinical atheromatosis progression over 2 Years in patients with different stages of CKD","volume":"11","author":"Gracia","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.08.046_bib42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jcin.2009.05.018","volume":"2","author":"Mehran","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2018.08.046_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000443616","article-title":"Arterial stiffness and chronic kidney disease","volume":"3","author":"Garnier","year":"2016","journal-title":"Pulse (Basel)"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.08.046_bib44","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2215\/CJN.04320709","article-title":"Coronary calcification in patients with chronic kidney disease and coronary artery disease","volume":"4","author":"Nakamura","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib45","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.08.046_bib46","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.RES.0000249379.55535.21","article-title":"Vascular calcification: pathobiological mechanisms and clinical implications","volume":"99","author":"Johnson","year":"2006","journal-title":"Circ. Res."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2018.08.046_bib47","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.08.046_bib49","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000133194.94939.42","article-title":"Vascular calcification: mechanisms and clinical ramifications","volume":"24","author":"Abedin","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2016.08.007","article-title":"Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients","volume":"92","author":"Chen","year":"2016","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","article-title":"Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease","volume":"2","author":"Chen","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.08.046_bib54","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00198-006-0154-6","article-title":"Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients","volume":"17","author":"Inaba","year":"2006","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib55","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00467-011-1822-0","article-title":"Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients","volume":"26","author":"Srivaths","year":"2011","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00467-013-2575-8","article-title":"High serum phosphorus and FGF 23 levels are associated with progression of coronary calcifications","volume":"29","author":"Srivaths","year":"2014","journal-title":"Pediatr. Nephrol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.08.046_bib57","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1253\/circj.CJ-14-0735","article-title":"Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification","volume":"78","author":"Gross","year":"2014","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib60","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/bonekey.2015.39","article-title":"The role of fetuin-A in mineral trafficking and deposition","volume":"4","author":"Cai","year":"2015","journal-title":"BoneKEy Rep."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.08.046_bib61","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","article-title":"Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications","volume":"30","author":"Morena","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6620","key":"10.1016\/j.atherosclerosis.2018.08.046_bib62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.molmed.2012.12.008","article-title":"Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization","volume":"19","author":"Schurgers","year":"2013","journal-title":"Trends Mol. Med."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.08.046_bib64","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib65","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2018.08.046_bib66","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib67","first-page":"RA1","article-title":"The mechanism of vascular calcification - a systematic review","volume":"18","author":"Karwowski","year":"2012","journal-title":"Med. Sci. Mon."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib68","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MOL.0b013e32832dd832","article-title":"Dyslipidemia of kidney disease","volume":"20","author":"Attman","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib69","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2215\/CJN.01930408","article-title":"Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease","volume":"3","author":"McCullough","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib70","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5414\/CN107515","article-title":"The association between coronary artery calcification progression and loss of bone density in non-dialyzed CKD patients","volume":"78","author":"Watanabe","year":"2012","journal-title":"Clin. Nephrol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.08.046_bib71","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.08.046_bib72","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib73","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","article-title":"Vascular calcification in chronic kidney disease: different bricks in the wall?","volume":"91","author":"Vervloet","year":"2017","journal-title":"Kidney Int."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2018.08.046_bib74","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/archinternmed.2009.382","article-title":"Annual progression of coronary calcification in trials of preventive therapies: a systematic review","volume":"169","author":"McCullough","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib75","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"26","key":"10.1016\/j.atherosclerosis.2018.08.046_bib76","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2215\/CJN.01760215","article-title":"Clinical and practical use of calcimimetics in dialysis patients with secondary hyperparathyroidism","volume":"11","author":"Bover","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001363","article-title":"Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial","volume":"3","author":"Wheeler","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib79","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2018.08.046_bib80","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib81","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000294405","article-title":"Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients","volume":"31","author":"Shantouf","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib83","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacc.2006.10.001","volume":"49","author":"Greenland","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib84","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcmg.2008.12.031","article-title":"Diagnostic and prognostic value of absence of coronary artery calcification","volume":"2","author":"Sarwar","year":"2009","journal-title":"JACC Cardiovasc. Imag."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.08.046_bib85","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2009.08.088","article-title":"Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the \"warranty period\" for remaining normal?","volume":"55","author":"Min","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2018.08.046_bib86","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/CIRCULATIONAHA.106.674143","article-title":"Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"115","author":"Kronmal","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2007.05.027","article-title":"Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness","volume":"197","author":"Taylor","year":"2008","journal-title":"Atherosclerosis"},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2018.08.046_bib88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s003920070099","article-title":"Coronary calcification: insights from sudden coronary death victims","volume":"89","author":"Burke","year":"2000","journal-title":"Z. Kardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCOUTCOMES.109.893396","article-title":"Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"3","author":"Nasir","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"25 Pt B","key":"10.1016\/j.atherosclerosis.2018.08.046_bib90","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the american college of cardiology\/american heart association task force on practice guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib91","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfv020","article-title":"Pro: cardiovascular calcifications are clinically relevant","volume":"30","author":"Bover","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4 Suppl 3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib92","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","author":"K\/DOQI Workgroup","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib93","series-title":"Chapter 8: Cardiovascular Disease in Patients with ESRD. 2017 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","author":"United States Renal Data System","year":"2017"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib94","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.08.046_bib95","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/ndt\/gfn393","article-title":"Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?","volume":"23","author":"Floege","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.08.046_bib96","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2018.08.046_bib97","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/ndt\/gfl291","article-title":"The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients","volume":"21","author":"Tomiyama","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib98","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.08.046_bib99","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01250209","article-title":"Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function","volume":"4","author":"Tuttle","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.08.046_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133938","article-title":"New conclusions regarding comparison of sevelamer and calcium-based phosphate binders in coronary-artery calcification for dialysis patients: a meta-analysis of randomized controlled trials","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5414\/CNP74012","article-title":"Impact of phosphate binder type on coronary artery calcification in hemodialysis patients","volume":"74","author":"Shantouf","year":"2010","journal-title":"Clin. Nephrol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib102","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial","volume":"62","author":"Di Iorio","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib103","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfv021","article-title":"Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease","volume":"30","author":"Zoccali","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.08.046_bib104","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s40265-017-0758-5","article-title":"A review of phosphate binders in chronic kidney disease: incremental progress or just higher costs?","volume":"77","author":"Peter","year":"2017","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.046_bib105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib106","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14740338.2014.907791","article-title":"Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles","volume":"13","author":"Locatelli","year":"2014","journal-title":"Expet Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156891","article-title":"Comparative effectiveness of phosphate binders in patients with chronic kidney disease: a systematic review and network meta-analysis","volume":"11","author":"Sekercioglu","year":"2016","journal-title":"PLoS One"},{"issue":"9900","key":"10.1016\/j.atherosclerosis.2018.08.046_bib108","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib109","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials","volume":"68","author":"Palmer","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.046_bib110","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/j.1523-1755.2004.66015.x","article-title":"Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro","volume":"66","author":"Yang","year":"2004","journal-title":"Kidney Int."},{"issue":"5291","key":"10.1016\/j.atherosclerosis.2018.08.046_bib111","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/230228a0","article-title":"Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism","volume":"230","author":"Lawson","year":"1971","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.046_bib112","doi-asserted-by":"crossref","first-page":"160","DOI":"10.25100\/cm.v47i3.2148","article-title":"Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5","volume":"47","author":"Restrepo Valencia","year":"2016","journal-title":"Colomb. Med. (Cali)"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.08.046_bib113","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2011.218","article-title":"Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism","volume":"8","author":"Quarles","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib114","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2018.08.046_bib115","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","article-title":"Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2018.08.046_bib116","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","article-title":"Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats","volume":"32","author":"Leifheit-Nestler","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.08.046_bib117","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ndt\/gfx060","article-title":"Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis","volume":"32","author":"Panizo","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1735-1995.175144","article-title":"The effect of vitamin D administration on serum leptin and adiponectin levels in end-stage renal disease patients on hemodialysis with vitamin D deficiency: a placebo-controlled double-blind clinical trial","volume":"21","author":"Naini","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2369-14-199","article-title":"Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies","volume":"14","author":"Zheng","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib120","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"10","author":"Kumar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2018.08.046_bib121","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1248\/bpb1978.4.718","article-title":"Experimental atherosclerosis in rats fed a vitamin D, cholesterol-rich diet","volume":"4","author":"Kunitomo","year":"1981","journal-title":"J. Pharmacobio-Dyn"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.08.046_bib122","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","article-title":"Vitamin D receptor activators can protect against vascular calcification","volume":"19","author":"Mathew","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib123","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.08.046_bib124","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.046_bib125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12882-016-0367-7","article-title":"Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients","volume":"17","author":"Ng","year":"2016","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.atherosclerosis.2018.08.046_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int. Suppl."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018313492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018313492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T19:33:48Z","timestamp":1661888028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018313492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":126,"alternative-id":["S0021915018313492"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.046","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}